PCA Investment Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,422
| Closed | -$208K | – | 110 |
|
|
2024
Q4 | $208K | Buy |
2,422
+90
| +4% | +$7.74K | 0.1% | 136 |
|
|
2024
Q3 | $278K | Buy |
2,332
+2
| +0.1% | +$238 | 0.13% | 108 |
|
|
2024
Q2 | $333K | Buy |
2,330
+302
| +15% | +$43.1K | 0.17% | 81 |
|
|
2024
Q1 | $260K | Sell |
2,028
-1
| -0% | -$128 | 0.15% | 97 |
|
|
2023
Q4 | $210K | Buy |
+2,029
| New | +$210K | 0.14% | 111 |
|
|
2023
Q3 | – | Sell |
-1,728
| Closed | -$140K | – | 318 |
|
|
2023
Q2 | $140K | Buy |
+1,728
| New | +$140K | 0.08% | 157 |
|